{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:17:27Z","timestamp":1792099047789,"version":"4.4.0"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12985-017-0845-y","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T09:27:42Z","timestamp":1505294862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Hepatitis delta: virological and clinical aspects"],"prefix":"10.1186","volume":"14","author":[{"given":"Luan Felipo","family":"Botelho-Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Pinheiro Alves","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alcione de Oliveira","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Miguel Villalobos","family":"Salcedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deusilene Souza","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,13]]},"reference":[{"key":"845_CR1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/gut.18.12.997","volume":"18","author":"M Rizzetto","year":"1977","unstructured":"Rizzetto M, Canese MG, Aric\u00f2 S, Crivelli O, Trepo C, Bonino F, et al. Immunofluorescence detection of new antigen-antibody system (delta\/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. [Internet]. 1977;18:997\u20131003. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/75123 . Cited 29 Mar 2016.","journal-title":"Gut. [Internet]"},{"key":"845_CR2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/path.1711280402","volume":"128","author":"MG Canese","year":"1979","unstructured":"Canese MG, Rizzetto M, Arico S, Crivelli O, Zanetti AR, Macchiorlatti E, et al. An ultrastructural and immunohistochemical study on the delta antigen associated with the hepatitis B virus. J Pathol. [Internet]. 1979;128:169\u201375. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/392063 . Cited 29 Mar 2016.","journal-title":"J Pathol. [Internet]"},{"key":"845_CR3","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/infdis\/141.5.590","volume":"141","author":"M Rizzetto","year":"1980","unstructured":"Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL, Purcell RH. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis. [Internet]. 1980;141:590\u2013602. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6989929 . Cited 29 Mar 2016.","journal-title":"J Infect Dis. [Internet]"},{"key":"845_CR4","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0140-6736(80)91678-5","volume":"1","author":"M Rizzetto","year":"1980","unstructured":"Rizzetto M, Purcell RH, Gerin JL. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers. Lancet (London, England). [Internet]. 1980;1:1215\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6104036 . Cited 29 Mar 2016.","journal-title":"Lancet (London, England). [Internet]"},{"key":"845_CR5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4049\/jimmunol.125.1.318","volume":"125","author":"M Rizzetto","year":"1980","unstructured":"Rizzetto M, Shih JW, Gerin JL. The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen. J Immunol. [Internet]. 1980;125:318\u201324. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6769999 . Cited 29 Mar 2016.","journal-title":"J Immunol. [Internet]"},{"issue":"Suppl 1","key":"845_CR6","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S1590-8658(10)60687-1","volume":"43","author":"A Smedile","year":"2011","unstructured":"Smedile A, Rizzetto M. HDV: thirty years later. Dig Liver Dis. [Internet]. 2011;43(Suppl 1):S15\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21195366 .","journal-title":"Dig Liver Dis. [Internet]"},{"key":"845_CR7","doi-asserted-by":"crossref","unstructured":"Bonino F, Hoyer B, Ford E, Shih JW, Purcell RH, Gerin JL. The delta agent: HBsAg particles with delta antigen and RNA in the serum of an HBV carrier. Hepatology [Internet]. 1:127\u201331. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6169614 . Cited 29 Mar 2016.","DOI":"10.1002\/hep.1840010207"},{"key":"845_CR8","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1073\/pnas.77.10.6124","volume":"77","author":"M Rizzetto","year":"1980","unstructured":"Rizzetto M, Hoyer B, Canese MG, Shih JW, Purcell RH, Gerin JL. Delta agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci USA. [Internet]. 1980;77:6124\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6934539 . Cited 6 June 2016.","journal-title":"Proc Natl Acad Sci USA. [Internet]"},{"key":"845_CR9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/323558a0","volume":"323","author":"A Kos","year":"1986","unstructured":"Kos A, Dijkema R, Arnberg AC, van der Meide PH, Schellekens H. The hepatitis delta (delta) virus possesses a circular RNA. Nature. [Internet]. 1986;323:558\u201360. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2429192 . Cited 6 June 2016.","journal-title":"Nature. [Internet]"},{"key":"845_CR10","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1073\/pnas.86.6.1831","volume":"86","author":"HN Wu","year":"1989","unstructured":"Wu HN, Lin YJ, Lin FP, Makino S, Chang MF, Lai MM. Human hepatitis delta virus RNA subfragments contain an autocleavage activity. Proc Natl Acad Sci U S A. [Internet]. 1989;86:1831\u20135. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2648383 . Cited 6 June 2016.","journal-title":"Proc Natl Acad Sci U S A. [Internet]"},{"key":"845_CR11","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1126\/science.1129308","volume":"313","author":"K Salehi-Ashtiani","year":"2006","unstructured":"Salehi-Ashtiani K, Lupt\u00e1k A, Litovchick A, Szostak JW. A genomewide search for ribozymes reveals an HDV-like sequence in the human CPEB3 gene. Science. [Internet]. 2006;313:1788\u201392. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16990549 . Cited 6 June 2016.","journal-title":"Science. [Internet]"},{"key":"845_CR12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1126\/science.2492676","volume":"243","author":"AD Branch","year":"1989","unstructured":"Branch AD, Benenfeld BJ, Baroudy BM, Wells FV, Gerin JL, Robertson HD. An ultraviolet-sensitive RNA structural element in a viroid-like domain of the hepatitis delta virus. Science. [Internet]. 1989;243:649\u201352. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2492676 . Cited 6 June 2016.","journal-title":"Science. [Internet]"},{"key":"845_CR13","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1128\/JVI.67.12.6965-6972.1993","volume":"67","author":"TB Fu","year":"1993","unstructured":"Fu TB, Taylor J. The RNAs of hepatitis delta virus are copied by RNA polymerase II in nuclear homogenates. J Virol. [Internet]. 1993;67:6965\u201372. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8230419 . Cited 6 June 2016.","journal-title":"J Virol. [Internet]"},{"key":"845_CR14","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1128\/JVI.79.13.7951-7958.2005","volume":"79","author":"MMC Lai","year":"2005","unstructured":"Lai MMC. RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus. J Virol. [Internet]. 2005;79:7951\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15956541 . Cited 6 June 2016.","journal-title":"J Virol. [Internet]"},{"key":"845_CR15","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1128\/JVI.01758-07","volume":"82","author":"J Chang","year":"2008","unstructured":"Chang J, Nie X, Chang HE, Han Z, Taylor J. Transcription of hepatitis delta virus RNA by RNA polymerase II. J Virol. [Internet]. 2008;82:1118\u201327. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18032511 . Cited 6 July 2016.","journal-title":"J Virol. [Internet]"},{"key":"845_CR16","first-page":"1","volume":"307","author":"JM Taylor","year":"2006","unstructured":"Taylor JM. Structure and replication of hepatitis delta virus RNA. Curr Top Microbiol Immunol. [Internet]. 2006;307:1\u201323. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16903218 . Cited 6 June 2016.","journal-title":"Curr Top Microbiol Immunol. [Internet]"},{"issue":"Suppl 1","key":"845_CR17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/liv.13018","volume":"36","author":"M Rizzetto","year":"2016","unstructured":"Rizzetto M. The adventure of delta. Liver Int. [Internet]. 2016;36(Suppl 1):135\u201340. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26725911 . Cited 6 June 2016.","journal-title":"Liver Int. [Internet]"},{"key":"845_CR18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.virol.2005.09.033","volume":"344","author":"JM Taylor","year":"2006","unstructured":"Taylor JM. Hepatitis delta virus. Virology. [Internet]. 2006;344:71\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16364738 . Cited 6 June 2016.","journal-title":"Virology. [Internet]"},{"key":"845_CR19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1128\/JVI.58.3.945-950.1986","volume":"58","author":"F Bonino","year":"1986","unstructured":"Bonino F, Heermann KH, Rizzetto M, Gerlich WH. Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope. J Virol. [Internet]. 1986;58:945\u201350. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3701932 . Cited 6 June 2016.","journal-title":"J Virol. [Internet]"},{"key":"845_CR20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(10)61931-9","volume":"378","author":"SA Hughes","year":"2011","unstructured":"Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet (London, England). [Internet]. 2011;378:73\u201385. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21511329 . Cited 6 June 2016.","journal-title":"Lancet (London, England). [Internet]"},{"key":"845_CR21","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/323508a0","volume":"323","author":"KS Wang","year":"1986","unstructured":"Wang KS, Choo QL, Weiner AJ, Ou JH, Najarian RC, Thayer RM, et al. Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature. [Internet]. 1986;323:508\u201314. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3762705 . Cited 6 June 2016.","journal-title":"Nature. [Internet]"},{"key":"845_CR22","doi-asserted-by":"crossref","unstructured":"Kuo MY, Chao M, Taylor J. Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J Virol. [Internet]. 1989;63:1945\u201350. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2649689 .","DOI":"10.1128\/JVI.63.5.1945-1950.1989"},{"key":"845_CR23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0006-291X(03)00338-3","volume":"303","author":"T-C Wang","year":"2003","unstructured":"Wang T-C, Chao M. Molecular cloning and expression of the hepatitis delta virus genotype IIb genome. Biochem Biophys Res Commun. [Internet]. 2003;303:357\u201363. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12646211 . Cited 6 June 2016.","journal-title":"Biochem Biophys Res Commun. [Internet]"},{"key":"845_CR24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/329343a0","volume":"329","author":"S Makino","year":"1987","unstructured":"Makino S, Chang MF, Shieh CK, Kamahora T, Vannier DM, Govindarajan S, et al. Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature. [Internet]. 1987;329:343\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3627276 . Cited 4 July 2016.","journal-title":"Nature. [Internet]"},{"key":"845_CR25","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1128\/JVI.65.5.2357-2361.1991","volume":"65","author":"JS Glenn","year":"1991","unstructured":"Glenn JS, White JM. Trans-dominant inhibition of human hepatitis delta virus genome replication. J Virol. [Internet]. 1991;65:2357\u201361. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2016764 . Cited 4 July 2016.","journal-title":"J Virol. [Internet]"},{"key":"845_CR26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/viro.1996.0191","volume":"218","author":"SY Sheu","year":"1996","unstructured":"Sheu SY, Chen KL, Lee YW, Lo SJ. No intermolecular interaction between the large hepatitis delta antigens is required for the secretion with hepatitis B surface antigen: a model of empty HDV particle. Virology. [Internet]. 1996;218:275\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8615035 . Cited 4 July 2016.","journal-title":"Virology. [Internet]"},{"key":"845_CR27","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1099\/0022-1317-83-10-2507","volume":"83","author":"G-T Sheu","year":"2002","unstructured":"Sheu G-T. Initiation of hepatitis delta virus (HDV) replication: HDV RNA encoding the large delta antigen cannot replicate. J Gen Virol. [Internet]. 2002;83:2507\u201313. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12237434 . Cited 4 July 2016.","journal-title":"J Gen Virol. [Internet]"},{"key":"845_CR28","first-page":"123","volume":"353","author":"JL Casey","year":"2012","unstructured":"Casey JL. Control of ADAR1 editing of hepatitis delta virus RNAs. Curr Top Microbiol Immunol. [Internet]. 2012;353:123\u201343. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21732238 . Cited 5 July 2016.","journal-title":"Curr Top Microbiol Immunol. [Internet]"},{"key":"845_CR29","first-page":"67","volume":"307","author":"JL Casey","year":"2006","unstructured":"Casey JL. RNA editing in hepatitis delta virus. Curr Top Microbiol Immunol. [Internet]. 2006;307:67\u201389. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16903221 . Cited 5 July 2016.","journal-title":"Curr Top Microbiol Immunol. [Internet]"},{"key":"845_CR30","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1073\/pnas.89.15.7149","volume":"89","author":"JL Casey","year":"1992","unstructured":"Casey JL, Bergmann KF, Brown TL, Gerin JL. Structural requirements for RNA editing in hepatitis delta virus: evidence for a uridine-to-cytidine editing mechanism. Proc Natl Acad Sci USA. [Internet]. 1992;89:7149\u201353. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1496009 . Cited 5 July 2016.","journal-title":"Proc Natl Acad Sci USA. [Internet]"},{"key":"845_CR31","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1128\/JVI.69.12.7593-7600.1995","volume":"69","author":"JL Casey","year":"1995","unstructured":"Casey JL, Gerin JL. Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA. J Virol. [Internet]. 1995;69:7593\u2013600. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7494266 . Cited 5 July 2016.","journal-title":"J Virol. [Internet]"},{"key":"845_CR32","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0042-6822(90)90335-O","volume":"178","author":"YC Chao","year":"1990","unstructured":"Chao YC, Chang MF, Gust I, Lai MM. Sequence conservation and divergence of hepatitis delta virus RNA. Virology. [Internet]. 1990;178:384\u201392. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2219700 . Cited 4 July 2016.","journal-title":"Virology. [Internet]"},{"key":"845_CR33","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1128\/JVI.62.7.2403-2410.1988","volume":"62","author":"MF Chang","year":"1988","unstructured":"Chang MF, Baker SC, Soe LH, Kamahora T, Keck JG, Makino S, et al. Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol. [Internet]. 1988;62:2403\u201310. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3373572 . Cited 5 July 2016.","journal-title":"J Virol. [Internet]"},{"key":"845_CR34","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1128\/JVI.73.12.10540-10545.1999","volume":"73","author":"JJ Mu","year":"1999","unstructured":"Mu JJ, Wu HL, Chiang BL, Chang RP, Chen DS, Chen PJ. Characterization of the phosphorylated forms and the phosphorylated residues of hepatitis delta virus delta antigens. J Virol. [Internet]. 1999;73:10540\u20135. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10559375 . Cited 5 July 2016.","journal-title":"J Virol. [Internet]"},{"key":"845_CR35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.virol.2003.10.024","volume":"319","author":"J-J Mu","year":"2004","unstructured":"Mu J-J, Tsay Y-G, Juan L-J, Fu T-F, Huang W-H, Chen D-S, et al. The small delta antigen of hepatitis delta virus is an acetylated protein and acetylation of lysine 72 may influence its cellular localization and viral RNA synthesis. Virology. 2004;319:60\u201370.","journal-title":"Virology"},{"key":"845_CR36","doi-asserted-by":"crossref","first-page":"13325","DOI":"10.1128\/JVI.78.23.13325-13334.2004","volume":"78","author":"Y-J Li","year":"2004","unstructured":"Li Y-J, Stallcup MR, Lai MMC. Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication. J Virol. [Internet]. 2004;78:13325\u201334. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15542683 . Cited 5 July 2016.","journal-title":"J Virol. [Internet]"},{"key":"845_CR37","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.1598578","volume":"256","author":"JS Glenn","year":"1992","unstructured":"Glenn JS, Watson JA, Havel CM, White JM. Identification of a prenylation site in delta virus large antigen. Science. [Internet]. 1992;256:1331\u20133. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1598578 . Cited 5 July 2016.","journal-title":"Science. [Internet]"},{"key":"845_CR38","first-page":"91","volume":"307","author":"WH Huang","year":"2006","unstructured":"Huang WH, Chen CW, Wu HL, Chen PJ. Post-translational modification of delta antigen of hepatitis D virus. Curr Top Microbiol Immunol. [Internet]. 2006;307:91\u2013112. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16903222 . Cited 5 July 2016.","journal-title":"Curr Top Microbiol Immunol. [Internet]"},{"key":"845_CR39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.virusres.2012.08.021","volume":"170","author":"C-R Huang","year":"2012","unstructured":"Huang C-R, Wang RYL, Hsu S-C, Lo SJ. Lysine-71 in the large delta antigen of hepatitis delta virus clade 3 modulates its localization and secretion. Virus Res. 2012;170:75\u201384.","journal-title":"Virus Res"},{"key":"845_CR40","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1128\/JVI.02083-09","volume":"84","author":"S-Y Hong","year":"2010","unstructured":"Hong S-Y, Chen P-J. Phosphorylation of serine 177 of the small hepatitis delta antigen regulates viral antigenomic RNA replication by interacting with the processive RNA polymerase II. J Virol. [Internet]. 2010;84:1430\u20138. Available from: http:\/\/jvi.asm.org\/cgi\/doi\/10.1128\/JVI.02083-09 . Cited 9 Aug 2017.","journal-title":"J Virol. [Internet]"},{"key":"845_CR41","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1099\/vir.0.19690-0","volume":"85","author":"K-P Tan","year":"2004","unstructured":"Tan K-P, Shih K-N, Lo SJ. Ser-123 of the large antigen of hepatitis delta virus modulates its cellular localization to the nucleolus, SC-35 speckles or the cytoplasm. J Gen Virol [Internet]. 2004;85:1685\u201394. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15166453 . Cited 9 Aug 2017.","journal-title":"J Gen Virol [Internet]"},{"key":"845_CR42","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1128\/JVI.02083-09","volume":"84","author":"S-Y Hong","year":"2010","unstructured":"Hong S-Y, Chen P-J. Phosphorylation of serine 177 of the small hepatitis delta antigen regulates viral antigenomic RNA replication by interacting with the processive RNA polymerase II. J Virol. [Internet]. 2010;84:1430\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19923176 . Cited 5 Jul 2016.","journal-title":"J Virol. [Internet]"},{"key":"845_CR43","doi-asserted-by":"crossref","first-page":"9087","DOI":"10.1128\/JVI.75.19.9087-9095.2001","volume":"75","author":"JJ Mu","year":"2001","unstructured":"Mu JJ, Chen DS, Chen PJ. The conserved serine 177 in the delta antigen of hepatitis delta virus is one putative phosphorylation site and is required for efficient viral RNA replication. J Virol. [Internet]. 2001;75:9087\u201395. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11533172 . Cited 5 July 2016.","journal-title":"J Virol. [Internet]"},{"key":"845_CR44","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1128\/JVI.62.8.2674-2679.1988","volume":"62","author":"L Sharmeen","year":"1988","unstructured":"Sharmeen L, Kuo MY, Dinter-Gottlieb G, Taylor J. Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J Virol. [Internet]. 1988;62:2674\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2455816 . Cited 5 July 2016.","journal-title":"J Virol. [Internet]"},{"key":"845_CR45","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/26912","volume":"395","author":"AR Ferr\u00e9-D\u2019Amar\u00e9","year":"1998","unstructured":"Ferr\u00e9-D\u2019Amar\u00e9 AR, Zhou K, Doudna JA. Crystal structure of a hepatitis delta virus ribozyme. Nature. [Internet]. 1998;395:567\u201374. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9783582 . Cited 5 July 2016.","journal-title":"Nature. [Internet]"},{"key":"845_CR46","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1128\/MCB.10.10.5575","volume":"10","author":"HN Wu","year":"1990","unstructured":"Wu HN, Lai MM. RNA conformational requirements of self-cleavage of hepatitis delta virus RNA. Mol Cell Biol. [Internet]. 1990;10:5575\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2398903 . Cited 5 July 2016.","journal-title":"Mol Cell Biol. [Internet]"},{"key":"845_CR47","first-page":"28179","volume":"6","author":"C-HT Webb","year":"2016","unstructured":"Webb C-HT, Nguyen D, Myszka M, Lupt\u00e1k A, Jimenez RM, Polanco JA, et al. Topological constraints of structural elements in regulation of catalytic activity in HDV-like self-cleaving ribozymes. Sci Rep. [Internet] Nature Publishing Group. 2016;6:28179. Available from: http:\/\/www.nature.com\/articles\/srep28179 . Cited 5 July 2016.","journal-title":"Sci Rep. [Internet] Nature Publishing Group"},{"key":"845_CR48","first-page":"5631","volume":"88","author":"SF Elena","year":"1991","unstructured":"Elena SF, Dopazo J, Florest R, Diener TO, Moya A. Phylogeny of viroids, viroidlike satellite RNAs, and the viroidlike domain of hepatitis 6 virus RNA. Evolution (N Y). 1991;88:5631\u20134.","journal-title":"Evolution (N Y)"},{"key":"845_CR49","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3390\/v1030818","volume":"1","author":"C-H Tseng","year":"2009","unstructured":"Tseng C-H, Lai MMC. Hepatitis delta virus RNA replication. Viruses. [Internet]. 2009;1:818\u201331. Available from: http:\/\/www.mdpi.com\/1999-4915\/1\/3\/818\/ . Cited 7 Aug 2017.","journal-title":"Viruses. [Internet]"},{"key":"845_CR50","first-page":"a021568","volume":"5","author":"JM Taylor","year":"2015","unstructured":"Taylor JM, Hepatitis D. Virus replication. Cold spring Harb. Perspect Med. [Internet]. 2015;5:a021568. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26525452 . Cited 4 Aug 2017.","journal-title":"Perspect Med. [Internet]"},{"key":"845_CR51","doi-asserted-by":"crossref","unstructured":"Chao M, Wang T-C, Lin C-C, Wang RY-L, Lin W-B, Lee S-E, et al. Analyses of a whole-genome inter-clade recombination map of hepatitis delta virus suggest a host polymerase-driven and viral RNA structure-promoted template-switching mechanism for viral RNA recombination. Oncotarget. [Internet]. 2017; Available from: http:\/\/www.oncotarget.com\/fulltext\/18339 . Cited 7 Aug 2017.","DOI":"10.18632\/oncotarget.18339"},{"key":"845_CR52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4161\/rna.8.2.14238","volume":"8","author":"R Flores","year":"2011","unstructured":"Flores R, Grubb D, Elleuch A, Nohales M-\u00c1, Delgado S, Gago S. Rolling-circle replication of viroids, viroid-like satellite RNAs and hepatitis delta virus: variations on a theme. RNA Biol. [Internet]. 2011;8:200\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21358283 . Cited 5 July 2016.","journal-title":"RNA Biol. [Internet]"},{"key":"845_CR53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1743-422X-10-239","volume":"10","author":"WH Gerlich","year":"2013","unstructured":"Gerlich WH. Medical virology of hepatitis B: how it began and where we are now. Virol J. [Internet]. 2013;10:239. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23870415 . Cited 5 July 2016.","journal-title":"Virol J. [Internet]"},{"key":"845_CR54","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3390\/ijms15022892","volume":"15","author":"K Watashi","year":"2014","unstructured":"Watashi K, Urban S, Li W, Wakita T. NTCP and beyond: opening the door to unveil hepatitis B virus entry. Int J Mol Sci. 2014;15:2892\u2013905.","journal-title":"Int J Mol Sci"},{"key":"845_CR55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3350\/cmh.2015.21.3.193","volume":"21","author":"J Li","year":"2015","unstructured":"Li J, Tong S. From DCPD to NTCP: the long journey towards identifying a functional hepatitis B virus receptor. Clin Mol Hepatol. [Internet]. 2015;21:193\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26523264 . Cited 5 July 2016.","journal-title":"Clin Mol Hepatol. [Internet]"},{"key":"845_CR56","first-page":"annurev-cellbio","volume":"31","author":"W Li","year":"2015","unstructured":"Li W. The hepatitis B virus receptor. Annu Rev Cell Dev Biol. [Internet]. 2015;31:annurev-cellbio-100814-125241. Available from: http:\/\/www.annualreviews.org\/doi\/10.1146\/annurev-cellbio-100814-125241 .","journal-title":"Annu Rev Cell Dev Biol. [Internet]"},{"key":"845_CR57","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1128\/JVI.66.2.914-921.1992","volume":"66","author":"YP Xia","year":"1992","unstructured":"Xia YP, Yeh CT, Ou JH, Lai MM. Characterization of nuclear targeting signal of hepatitis delta antigen: nuclear transport as a protein complex. J Virol. [Internet]. 1992;66:914\u201321. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1731113 . Cited 5 July 2016.","journal-title":"J Virol. [Internet]"},{"key":"845_CR58","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1017\/S1355838202026432","volume":"8","author":"JP Tavanez","year":"2002","unstructured":"Tavanez JP, Cunha C, Silva MCA, David E, Monjardino J, Carmo-Fonseca M. Hepatitis delta virus ribonucleoproteins shuttle between the nucleus and the cytoplasm. RNA. [Internet]. 2002;8:637\u201346. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12022230 . Cited 6 July 2016.","journal-title":"RNA. [Internet]"},{"key":"845_CR59","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2007.07.034","volume":"370","author":"C Alves","year":"2008","unstructured":"Alves C, Freitas N, Cunha C. Characterization of the nuclear localization signal of the hepatitis delta virus antigen. Virology. 2008;370:12\u201321.","journal-title":"Virology"},{"key":"845_CR60","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000371692","volume":"33","author":"H Yan","year":"2015","unstructured":"Yan H, Li W. Sodium taurocholate cotransporting polypeptide acts as a receptor for hepatitis B and D virus. Dig Dis. 2015;33:388\u201396.","journal-title":"Dig Dis"},{"key":"845_CR61","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1128\/MCB.20.16.6030-6039.2000","volume":"20","author":"LE Modahl","year":"2000","unstructured":"Modahl LE, Macnaughton TB, Zhu N, Johnson DL, Lai MM. RNA-dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases. Mol Cell Biol. [Internet]. 2000;20:6030\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10913185 . Cited 6 July 2016.","journal-title":"Mol Cell Biol. [Internet]"},{"key":"845_CR62","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/v2010189","volume":"2","author":"V Greco-Stewart","year":"2010","unstructured":"Greco-Stewart V, Pelchat M. Interaction of host cellular proteins with components of the Hepatitis Delta virus. Viruses. [Internet]. 2010;2:189\u2013212. Available from: www.mdpi.com\/journal\/viruses . Cited 6 July 2016.","journal-title":"Viruses. [Internet]"},{"key":"845_CR63","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/oxfordjournals.molbev.a026075","volume":"16","author":"JC Wu","year":"1999","unstructured":"Wu JC, Chiang TY, Shiue WK, Wang SY, Sheen IJ, Huang YH, et al. Recombination of hepatitis D virus RNA sequences and its implications. Mol Biol Evol. [Internet]. 1999;16:1622\u201332. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10555293 . Cited 7 Aug 2017.","journal-title":"Mol Biol Evol. [Internet]"},{"key":"845_CR64","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1128\/JVI.79.4.2221-2229.2005","volume":"79","author":"T-C Wang","year":"2005","unstructured":"Wang T-C, Chao M. RNA recombination of hepatitis delta virus in natural mixed-genotype infection and transfected cultured cells. J Virol. [Internet]. 2005;79:2221\u20139. Available from: http:\/\/jvi.asm.org\/cgi\/doi\/10.1128\/JVI.79.4.2221-2229.2005 . Cited 7 Aug 2017.","journal-title":"J Virol. [Internet]"},{"key":"845_CR65","unstructured":"Lin C-C, Lee C-C, Lin S-H, Huang P-J, Li H-P, Chang Y-S, et al. RNA recombination in hepatitis delta virus: identification of a novel naturally occurring recombinant. J Microbiol Immunol Infect. [Internet]. 2015; Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S168411821500910X . Cited 7 Aug 2017."},{"key":"845_CR66","first-page":"55","volume":"22","author":"BT Sy","year":"2015","unstructured":"Sy BT, Nguyen HM, Toan NL, Song LH, Tong HV, Wolboldt C, et al. Identification of a natural intergenotypic recombinant hepatitis delta virus genotype 1 and 2 in Vietnamese HBsAg-positive patients. J Viral Hepat. [Internet]. 2015;22:55\u201363. Available from: http:\/\/doi.wiley.com\/10.1111\/jvh.12228 . Cited 7 Aug 2017.","journal-title":"J Viral Hepat. [Internet]"},{"key":"845_CR67","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/j.jhep.2016.02.013","volume":"64","author":"C Sureau","year":"2016","unstructured":"Sureau C, Negro F. The hepatitis delta virus: replication and pathogenesis. J Hepatol. [Internet]. 2016;64:S102\u201316. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827816001203 . Cited 7 Aug 2017.","journal-title":"J Hepatol. [Internet]"},{"key":"845_CR68","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1128\/JVI.67.12.7659-7662.1993","volume":"67","author":"SB Hwang","year":"1993","unstructured":"Hwang SB, Lai MM. Isoprenylation mediates direct protein-protein interactions between hepatitis large delta antigen and hepatitis B virus surface antigen. J Virol. [Internet]. 1993;67:7659\u201362. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8230486 . Cited 6 July 2016.","journal-title":"J Virol. [Internet]"},{"key":"845_CR69","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1128\/JVI.78.5.2537-2544.2004","volume":"78","author":"N Radjef","year":"2004","unstructured":"Radjef N, Gordien E, Ivaniushina V, Gault E, Ana\u00efs P, Drugan T, et al. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol. [Internet]. 2004;78:2537\u201344. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14963156 . Cited 6 July 2016.","journal-title":"J Virol. [Internet]"},{"key":"845_CR70","first-page":"151","volume":"307","author":"P D\u00e9ny","year":"2006","unstructured":"D\u00e9ny P. Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades? Curr Top Microbiol Immunol. [Internet]. 2006;307:151\u201371. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16903225 . Cited 6 July 2016.","journal-title":"Curr Top Microbiol Immunol. [Internet]"},{"key":"845_CR71","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3201\/eid1209.060112","volume":"12","author":"F Gal Le","year":"2006","unstructured":"Le Gal F, Gault E, Ripault M-P, Serpaggi J, Trinchet J-C, Gordien E, et al. Eighth major clade for hepatitis delta virus. Emerg Infect Dis. [Internet]. 2006;12:1447\u201350. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17073101 . Cited 6 July 2016.","journal-title":"Emerg Infect Dis. [Internet]"},{"key":"845_CR72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(10)61931-9","volume":"378","author":"SA Hughes","year":"2011","unstructured":"Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet. 2011;378:73\u201385.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"845_CR73","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.1016\/S0168-8278(03)00331-3","volume":"39","author":"P Farci","year":"2003","unstructured":"Farci P. Delta hepatitis: an update. J Hepatol. [Internet]. 2003;39(Suppl 1):S212\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14708706 . Cited 6 July 2016.","journal-title":"J Hepatol. [Internet]"},{"key":"845_CR74","doi-asserted-by":"crossref","unstructured":"Rizzetto M, Ponzetto A, Forzani I. Hepatitis delta virus as a global health problem. Vaccine. [Internet]. 1990;8 Suppl:S10-4-3. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2183511 . Cited 6 July 2016.","DOI":"10.1016\/0264-410X(90)90207-3"},{"key":"845_CR75","first-page":"160","volume":"234","author":"AO Shakil","year":"1997","unstructured":"Shakil AO, Hadziyannis S, Hoofnagle JH, Di Bisceglie AM, Gerin JL, Casey JL. Geographic distribution and genetic variability of Hepatitis Delta virus genotype I. Virology. [Internet] Academic Press. 1997;234:160\u20137. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004268229798644X . Cited 6 July 2016.","journal-title":"Virology. [Internet] Academic Press"},{"key":"845_CR76","doi-asserted-by":"crossref","first-page":"9016","DOI":"10.1073\/pnas.90.19.9016","volume":"90","author":"JL Casey","year":"1993","unstructured":"Casey JL, Brown TL, Colan EJ, Wignall FS, Gerin JL. A genotype of hepatitis D virus that occurs in northern South America. Proc Natl Acad Sci USA. [Internet]. 1993;90:9016\u201320. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8415646 . Cited 6 July 2016.","journal-title":"Proc Natl Acad Sci USA. [Internet]"},{"key":"845_CR77","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4269\/ajtmh.2006.75.475","volume":"75","author":"R Paran\u00e1","year":"2006","unstructured":"Paran\u00e1 R, Kay A, Molinet F, Viana S, Silva LK, Salcedo JM, et al. HDV genotypes in the western Brazilian Amazon region: a preliminary report. Am J Trop Med Hyg. [Internet]. 2006;75:475\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16968924 . Cited 6 July 2016.","journal-title":"Am J Trop Med Hyg. [Internet]"},{"key":"845_CR78","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000431040","volume":"58","author":"LF Botelho-Souza","year":"2015","unstructured":"Botelho-Souza LF, Souza Vieira D, de Oliveira Dos Santos A, Cunha Pereira AV, Villalobos-Salcedo JM. Characterization of the genotypic profile of Hepatitis Delta virus: isolation of HDV Genotype-1 in the western Amazon region of Brazil. Intervirology. [Internet]. 2015;58:166\u201371. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26112316 . Cited 6 July 2016.","journal-title":"Intervirology. [Internet]"},{"key":"845_CR79","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1128\/JVI.64.11.5594-5599.1990","volume":"64","author":"F Imazeki","year":"1990","unstructured":"Imazeki F, Omata M, Ohto M. Heterogeneity and evolution rates of delta virus RNA sequences. J Virol. [Internet]. 1990;64:5594\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2214027 . Cited 6 July 2016.","journal-title":"J Virol. [Internet]"},{"issue":"Pt 5","key":"845_CR80","first-page":"1105","volume":"79","author":"JC Wu","year":"1998","unstructured":"Wu JC, Chiang TY, Sheen IJ. Characterization and phylogenetic analysis of a novel hepatitis D virus strain discovered by restriction fragment length polymorphism analysis. J Gen Virol. [Internet]. 1998;79(Pt 5):1105\u201313. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9603325 . Cited 6 July 2016.","journal-title":"J Gen Virol. [Internet]"},{"key":"845_CR81","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1099\/0022-1317-82-11-2709","volume":"82","author":"V Ivaniushina","year":"2001","unstructured":"Ivaniushina V, Radjef N, Alexeeva M, Gault E, Semenov S, Salhi M, et al. Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia. J Gen Virol. [Internet]. 2001;82:2709\u201318. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11602783 . Cited 6 July 2016.","journal-title":"J Gen Virol. [Internet]"},{"key":"845_CR82","doi-asserted-by":"crossref","first-page":"e18888","DOI":"10.1371\/journal.pone.0018888","volume":"6","author":"MV Alvarado-Mora","year":"2011","unstructured":"Alvarado-Mora MV, Fernandez MFG, Gomes-Gouv\u00eaa MS, de Azevedo Neto RS, Carrilho FJ, Pinho JRR. Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian population--how is the epidemiological situation? PLoS One. [Internet]. 2011;6:e18888. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21559488 . Cited 6 July 2016.","journal-title":"PLoS One. [Internet]"},{"key":"845_CR83","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.actatropica.2008.02.009","volume":"106","author":"MS Gomes-Gouv\u00eaa","year":"2008","unstructured":"Gomes-Gouv\u00eaa MS, do Pereira Soares MC, Guedes de Carvalho Mello IMV, Brito EMF, de Pereira Moia LJM, Bensabath G, et al. Hepatitis D and B virus genotypes in chronically infected patients from the eastern Amazon Basin. Acta Trop. [Internet]. 2008;106:149\u201355. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18420172 . Cited 6 July 2016.","journal-title":"Acta Trop. [Internet]"},{"key":"845_CR84","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1099\/vir.0.013615-0","volume":"90","author":"MS Gomes-Gouv\u00eaa","year":"2009","unstructured":"Gomes-Gouv\u00eaa MS, Soares MCP, Bensabath G, de Carvalho-Mello IMVG, Brito EMF, Souza OSC, et al. Hepatitis B virus and hepatitis delta virus genotypes in outbreaks of fulminant hepatitis (Labrea black fever) in the western Brazilian Amazon region. J Gen Virol. [Internet]. 2009;90:2638\u201343. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19605587 . Cited 6 July 2016.","journal-title":"J Gen Virol. [Internet]"},{"key":"845_CR85","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.meegid.2011.05.020","volume":"11","author":"MV Alvarado-Mora","year":"2011","unstructured":"Alvarado-Mora MV, Romano CM, Gomes-Gouv\u00eaa MS, Gutierrez MF, Carrilho FJ, Pinho JRR. Dynamics of hepatitis D (delta) virus genotype 3 in the Amazon region of South America. Infect Genet Evol. [Internet]. 2011;11:1462\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21645647 . Cited 6 July 2016.","journal-title":"Infect Genet Evol. [Internet]"},{"key":"845_CR86","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1099\/vir.0.18762-0","volume":"84","author":"S-P Ma","year":"2003","unstructured":"Ma S-P, Sakugawa H, Makino Y, Tadano M, Kinjo F, Saito A. The complete genomic sequence of hepatitis delta virus genotype IIb prevalent in Okinawa, Japan. J Gen Virol. [Internet]. 2003;84:461\u20134. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12560580 . Cited 6 July 2016.","journal-title":"J Gen Virol. [Internet]"},{"key":"845_CR87","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.virusres.2011.07.006","volume":"160","author":"LMF Barros","year":"2011","unstructured":"Barros LMF, Gomes-Gouv\u00eaa MS, Pinho JRR, Alvarado-Mora MV, Dos Santos A, Mendes-Corr\u00eaa MCJ, et al. Hepatitis Delta virus genotype 8 infection in Northeast Brazil: inheritance from African slaves? Virus Res. [Internet]. 2011;160:333\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21798297 . Cited 6 July 2016.","journal-title":"Virus Res. [Internet]"},{"key":"845_CR88","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4269\/ajtmh.2005.73.808","volume":"73","author":"S Viana","year":"2005","unstructured":"Viana S, Paran\u00e1 R, Moreira RC, Compri AP, Macedo V. High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. Am J Trop Med Hyg. [Internet]. 2005;73:808\u201314. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16222030 . Cited 6 July 2016.","journal-title":"Am J Trop Med Hyg. [Internet]"},{"key":"845_CR89","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2334-14-94","volume":"14","author":"MAE Crispim","year":"2014","unstructured":"Crispim MAE, Fraiji NA, Campello SC, Schriefer NA, Stefani MMA, Kiesslich D. Molecular epidemiology of hepatitis B and hepatitis delta viruses circulating in the western Amazon region, North Brazil. BMC Infect Dis. [Internet]. 2014;14:94. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24555665 . Cited 6 July 2016.","journal-title":"BMC Infect Dis. [Internet]"},{"key":"845_CR90","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0035-9203(88)90166-6","volume":"82","author":"JC Fonseca","year":"1988","unstructured":"Fonseca JC, Simonetti SR, Schatzmayr HG, Castej\u00f3n MJ, Ces\u00e1rio AL, Simonetti JP. Prevalence of infection with hepatitis delta virus (HDV) among carriers of hepatitis B surface antigen in Amazonas state, Brazil. Trans R Soc Trop Med Hyg. [Internet]. 1988;82:469\u201371. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3232188 . Cited 6 July 2016.","journal-title":"Trans R Soc Trop Med Hyg. [Internet]"},{"key":"845_CR91","first-page":"263","volume":"3","author":"M Vasconcelos","year":"2012","unstructured":"Vasconcelos M, Pereira DB, Paran\u00e1 R, Villalobos-Salcedo JM. Clinic and laboratory analysis of patients with hepatitis delta in Amazon region, Brazil. J Med Med Sci. [Internet]. 2012;3:263\u20139. Available from: http:\/\/www.interesjournals.org\/JMMS . Cited 6 July 2016.","journal-title":"J Med Med Sci. [Internet]"},{"issue":"Suppl 2","key":"845_CR92","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/S0037-86822004000700002","volume":"37","author":"WSM Braga","year":"2004","unstructured":"Braga WSM. Hepatitis B and D virus infection within Amerindians ethnic groups in the Brazilian Amazon: epidemiological aspects. Rev Soc Bras Med Trop. [Internet]. 2004;37(Suppl 2):9\u201313. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15586891 . Cited 6 July 2016.","journal-title":"Rev Soc Bras Med Trop. [Internet]"},{"key":"845_CR93","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1590\/S0037-86822012000600007","volume":"45","author":"WSM Braga","year":"2012","unstructured":"Braga WSM, da Castilho MC, Borges FG, Le\u00e3o JRDT, de Martinho ACS, Rodrigues IS, et al. Hepatitis D virus infection in the Western Brazilian Amazon - far from a vanishing disease. Rev Soc Bras Med Trop. [Internet]. 2012;45:691\u20135. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23295870 . Cited 6 July 2016.","journal-title":"Rev Soc Bras Med Trop. [Internet]"},{"key":"845_CR94","doi-asserted-by":"crossref","first-page":"e828","DOI":"10.1016\/j.ijid.2011.08.003","volume":"15","author":"MC Mendes-Correa","year":"2011","unstructured":"Mendes-Correa MC, Gomes-Gouv\u00eaa MS, Alvarado-Mora MV, Da Silva MH, L\u00e1zari C, Cavalcanti NCS, et al. Hepatitis delta in HIV\/HBV co-infected patients in Brazil: is it important? Int J Infect Dis. 2011;15:e828\u201332.","journal-title":"Int J Infect Dis"},{"key":"845_CR95","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-0032-1323628","volume":"32","author":"P Farci","year":"2012","unstructured":"Farci P, Niro GA. Clinical features of hepatitis D. Semin Liver Dis. [Internet]. 2012;32:228\u201336. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22932971 . Cited 7 July 2016.","journal-title":"Semin Liver Dis. [Internet]"},{"key":"845_CR96","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(82)90156-8","volume":"320","author":"A Smedile","year":"1982","unstructured":"Smedile A, Verme G, Cargnel A, Dentico P, Opolon P, Vergani D, et al. INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS B. Lancet. [Internet] Elsevier. 1982;320:945\u20137. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673682901568 . Cited 7 July 2016.","journal-title":"Lancet. [Internet] Elsevier"},{"issue":"Suppl 4","key":"845_CR97","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/0168-8278(91)90040-I","volume":"13","author":"M Rizzetto","year":"1991","unstructured":"Rizzetto M, Durazzo M. Hepatitis delta virus (HDV) infections. Epidemiological and clinical heterogeneity. J Hepatol. [Internet]. 1991;13(Suppl 4):S116\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1822503 . Cited 7 July 2016.","journal-title":"J Hepatol. [Internet]"},{"key":"845_CR98","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1053\/j.gastro.2009.01.052","volume":"136","author":"R Romeo","year":"2009","unstructured":"Romeo R, Del Ninno E, Rumi M, Russo A, Sangiovanni A, de Franchis R, et al. A 28-year study of the course of hepatitis \u0394 infection: a risk factor for cirrhosis and Hepatocellular carcinoma. Gastroenterology. 2009;136:1629\u201338.","journal-title":"Gastroenterology"},{"key":"845_CR99","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000282076","volume":"28","author":"J Grabowski","year":"2010","unstructured":"Grabowski J, Wedemeyer H. Hepatitis delta: immunopathogenesis and clinical challenges. Dig Dis. [Internet]. 2010;28:133\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20460901 . Cited 7 July 2016.","journal-title":"Dig Dis. [Internet]"},{"key":"845_CR100","first-page":"157","volume":"12","author":"A Smedile","year":"1994","unstructured":"Smedile A, Rizzetto M, Gerin JL. Advances in hepatitis D virus biology and disease. Prog Liver Dis. [Internet]. 1994;12:157\u201375. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7746872 . Cited 7 July 2016.","journal-title":"Prog Liver Dis. [Internet]"},{"key":"845_CR101","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1478-3231.2010.02320.x","volume":"31","author":"S Pascarella","year":"2011","unstructured":"Pascarella S, Negro F. Hepatitis D virus: An update. Liver Int. 2011;31:7\u201321.","journal-title":"Liver Int"},{"key":"845_CR102","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1128\/JCM.38.9.3311-3316.2000","volume":"38","author":"E Flodgren","year":"2000","unstructured":"Flodgren E, Bengtsson S, Knutsson M, Strebkova EA, Kidd AH, Alexeyev OA, et al. Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains. J Clin Microbiol. [Internet]. 2000;38:3311\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10970376 . Cited 7 July 2016.","journal-title":"J Clin Microbiol. [Internet]"},{"key":"845_CR103","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/infdis\/174.5.920","volume":"174","author":"JL Casey","year":"1996","unstructured":"Casey JL, Niro GA, Engle RE, Vega A, Gomez H, McCarthy M, et al. Hepatitis B virus (HBV)\/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F. J Infect Dis. [Internet]. 1996;174:920\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8896491 . Cited 7 July 2016.","journal-title":"J Infect Dis. [Internet]"},{"key":"845_CR104","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jhep.2009.10.036","volume":"52","author":"M Schaper","year":"2010","unstructured":"Schaper M, Rodriguez-Frias F, Jardi R, Tabernero D, Homs M, Ruiz G, et al. Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D. J Hepatol. 2010;52:658\u201364.","journal-title":"J Hepatol"},{"key":"845_CR105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00196050","volume":"183","author":"JL Lozano","year":"1994","unstructured":"Lozano JL, Crespo J, de la Cruz F, Casafont F, Lopez-Arias MJ, Mart\u00edn-Ramos L, et al. Correlation between hepatitis B viremia and the clinical and histological activity of chronic delta hepatitis. Med Microbiol Immunol. [Internet]. 1994;183:159\u201367. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7997189 . Cited 7 July 2016.","journal-title":"Med Microbiol Immunol. [Internet]"},{"key":"845_CR106","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/gut.46.3.420","volume":"46","author":"G Fattovich","year":"2000","unstructured":"Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European concerted action on viral hepatitis (Eurohep). Gut. [Internet]. 2000;46:420\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10673308 . Cited 7 July 2016.","journal-title":"Gut. [Internet]"},{"key":"845_CR107","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0168-8278(87)80574-3","volume":"5","author":"JM S\u00e1nchez-Tapias","year":"1987","unstructured":"S\u00e1nchez-Tapias JM, Mas A, Costa J, Bruguera M, Mayor A, Ballesta AM, et al. Recombinant alpha 2c-interferon therapy in fulminant viral hepatitis. J Hepatol. [Internet]. 1987;5:205\u201310. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3693864 . Cited 7 Jul 2016.","journal-title":"J Hepatol. [Internet]"},{"key":"845_CR108","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/hep.1840080526","volume":"8","author":"M Buti","year":"1988","unstructured":"Buti M, Esteban R, Roggendorf M, Fernandez J, Jardi R, Rashofer R, et al. Hepatitis D virus RNA in acute delta infection: serological profile and correlation with other markers of hepatitis D virus infection. Hepatology. [Internet]. 1988;8:1125\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3417234 . Cited 7 July 2016.","journal-title":"Hepatology. [Internet]"},{"key":"845_CR109","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/hep.1840140105","volume":"14","author":"R Jardi","year":"1991","unstructured":"Jardi R, Buti M, Rodriguez-Frias F, Garcia-Lafuente A, Sjogren MH, Esteban R, et al. Clinical significance of two forms of IgM antibody to hepatitis delta virus. Hepatology. [Internet]. 1991;14:25\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2066073 . Cited 7 July 2016.","journal-title":"Hepatology. [Internet]"},{"key":"845_CR110","first-page":"319","volume":"382","author":"M Buti","year":"1993","unstructured":"Buti M, Lopez-Talavera JC, Allende H, Jardi R, Esteban R, Guardia J. Serological diagnosis of chronic delta infection: correlation between serological markers and hepatitis delta virus RNA in hepatic tissue. Prog Clin Biol Res. [Internet]. 1993;382:319\u201323. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8502697 . Cited 7 July 2016.","journal-title":"Prog Clin Biol Res. [Internet]"},{"key":"845_CR111","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0166-0934(94)90163-5","volume":"50","author":"R Jardi","year":"1994","unstructured":"Jardi R, Buti M, Rodriguez F, Cotrina M, Allende H, Esteban R, et al. Comparative analysis of serological markers of chronic delta infection: HDV-RNA, serum HDAg and anti-HD IgM. J Virol Methods. [Internet]. 1994;50:59\u201366. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7714059 . Cited 7 July 2016.","journal-title":"J Virol Methods. [Internet]"},{"key":"845_CR112","first-page":"25","volume":"21","author":"R Jardi","year":"1995","unstructured":"Jardi R, Buti M, Cotrina M, Rodriguez F, Allende H, Esteban R, et al. Determination of hepatitis delta virus RNA by polymerase chain reaction in acute and chronic delta infection. Hepatology. [Internet] WB Saunders. 1995;21:25\u20139. Available from: http:\/\/doi.wiley.com\/10.1002\/hep.1840210106 . Cited 7 July 2016.","journal-title":"Hepatology. [Internet] WB Saunders"},{"key":"845_CR113","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-9071(199605)49:1<66::AID-JMV11>3.0.CO;2-0","volume":"49","author":"M Buti","year":"1996","unstructured":"Buti M, Jardi R, Allende H, Cotrina M, Rodriguez F, Viladomiu L, et al. Chronic delta hepatitis: is the prognosis worse when associated with hepatitis C virus and human immunodeficiency virus infections? J Med Virol. [Internet]. 1996;49:66\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8732862 . Cited 7 July 2016.","journal-title":"J Med Virol. [Internet]"},{"key":"845_CR114","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","volume":"371","author":"D Schuppan","year":"2008","unstructured":"Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. (London, England) [Internet] NIH Public Access. 2008;371:838\u201351. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18328931 . Cited 8 July 2016.","journal-title":"Lancet. (London, England) [Internet] NIH Public Access"},{"key":"845_CR115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11908-011-0233-5","volume":"14","author":"GA Niro","year":"2012","unstructured":"Niro GA, Smedile A. Current concept in the pathophysiology of hepatitis delta infection. Curr Infect Dis Rep. [Internet]. 2012;14:9\u201314. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22161240 . Cited 8 July 2016.","journal-title":"Curr Infect Dis Rep. [Internet]"},{"key":"845_CR116","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.1840060613","volume":"6","author":"G Verme","year":"1986","unstructured":"Verme G, Amoroso P, Lettieri G, Pierri P, David E, Sessa F, et al. A histological study of hepatitis delta virus liver disease. Hepatology. [Internet]. 1986;6:1303\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3793008 . Cited 8 July 2016.","journal-title":"Hepatology. [Internet]"},{"key":"845_CR117","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep.27102","volume":"60","author":"B Heidrich","year":"2014","unstructured":"Heidrich B, Yurdayd\u0131n C, Kaba\u00e7am G, Ratsch BA, Zachou K, Bremer B, et al. Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta. Hepatology. [Internet]. 2014;60:87\u201397. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24585488 . Cited 8 July 2016.","journal-title":"Hepatology. [Internet]"},{"key":"845_CR118","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cld.2013.05.007","volume":"17","author":"M Rizzetto","year":"2013","unstructured":"Rizzetto M, Alavian SM. Hepatitis delta: the rediscovery. Clin Liver Dis. 2013;17:475\u201387.","journal-title":"Clin Liver Dis"},{"key":"845_CR119","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-0032-1323629","volume":"32","author":"C Yurdaydin","year":"2012","unstructured":"Yurdaydin C. Treatment of chronic delta hepatitis. Semin Liver Dis. [Internet]. 2012;32:237\u201344. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22932972 . Cited 8 July 2016.","journal-title":"Semin Liver Dis. [Internet]"},{"key":"845_CR120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/apt.12788","volume":"40","author":"T Heller","year":"2014","unstructured":"Heller T, Rotman Y, Koh C, Clark S, Haynes-Williams V, Chang R, et al. Long-term therapy of chronic delta hepatitis with peginterferon alfa. Aliment Pharmacol Ther. [Internet]. 2014;40:93\u2013104. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24815494 . Cited 8 July 2016.","journal-title":"Aliment Pharmacol Ther. [Internet]"},{"key":"845_CR121","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2036.2005.02542.x","volume":"22","author":"GA Niro","year":"2005","unstructured":"Niro GA, Ciancio A, Tillman HL, Lagget M, Olivero A, Perri F, et al. Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study. Aliment Pharmacol Ther. [Internet]. 2005;22:227\u201332. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16091060 . Cited 8 July 2016.","journal-title":"Aliment Pharmacol Ther. [Internet]"},{"key":"845_CR122","first-page":"805","volume":"26","author":"A Erhardt","year":"2006","unstructured":"Erhardt A, Gerlich W, Starke C, Wend U, Donner A, Sagir A, et al. Treatment of chronic hepatitis delta with pegylated interferon-\u03b12b. Liver Int. [Internet] Blackwell Publishing Ltd. 2006;26:805\u201310. Available from: http:\/\/doi.wiley.com\/10.1111\/j.1478-3231.2006.01279.x . Cited 8 July 2016.","journal-title":"Liver Int. [Internet] Blackwell Publishing Ltd"},{"key":"845_CR123","first-page":"546","volume":"30","author":"DT Lau","year":"1999","unstructured":"Lau DT, Doo E, Park Y, Kleiner DE, Schmid P, Kuhns MC, et al. Lamivudine for chronic delta hepatitis. Hepatology. [Internet]. W.B. Saunders. 1999;30:546\u20139. Available from: http:\/\/doi.wiley.com\/10.1002\/hep.510300217 . Cited 8 July 2016.","journal-title":"Hepatology. [Internet]. W.B. Saunders"},{"key":"845_CR124","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/cid\/cis459","volume":"55","author":"G Kaba\u00e7am","year":"2012","unstructured":"Kaba\u00e7am G, Onder FO, Yakut M, Seven G, Karatayli SC, Karatayli E, et al. Entecavir treatment of chronic hepatitis D. Clin Infect Dis. [Internet]. 2012;55:645\u201350. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22573857 . Cited 8 July 2016.","journal-title":"Clin Infect Dis. [Internet]"},{"key":"845_CR125","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/135965350501000603","volume":"10","author":"F Gunsar","year":"2005","unstructured":"Gunsar F, Akarca US, Ersoz G, Kobak AC, Karasu Z, Yuce G, et al. Two-year interferon therapy with or without ribavirin in chronic delta hepatitis. Antivir Ther. [Internet]. 2005;10:721\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16218171 . Cited 8 July 2016.","journal-title":"Antivir Ther. [Internet]"},{"key":"845_CR126","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1365-2893.2007.00875.x","volume":"14","author":"C Yurdaydin","year":"2007","unstructured":"Yurdaydin C, Bozkaya H, Karaaslan H, Onder FO, Erkan OE, Yal\u00e7in K, et al. A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis. J Viral Hepat. [Internet]. 2007;14:812\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17927618 . Cited 8 Jul 2016.","journal-title":"J Viral Hepat. [Internet]"},{"key":"845_CR127","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.3748\/wjg.v18.i40.5793","volume":"18","author":"S Samiullah","year":"2012","unstructured":"Samiullah S, Bikharam D, Nasreen. Treatment of chronic hepatitis delta virus with peg-interferon and factors that predict sustained viral response. World J Gastroenterol. [Internet] Baishideng Publishing Group Inc. 2012;18:5793\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23155322 . Cited 8 July 2016.","journal-title":"World J Gastroenterol. [Internet] Baishideng Publishing Group Inc"},{"key":"845_CR128","first-page":"377","volume":"20","author":"L Gheorghe","year":"2011","unstructured":"Gheorghe L, Iacob S, Simionov I, Vadan R, Constantinescu I, Caruntu F, et al. Weight-based dosing regimen of peg-interferon \u03b1-2b for chronic hepatitis delta: a multicenter Romanian trial. J Gastrointestin Liver Dis. [Internet]. 2011;20:377\u201382. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22187703 . Cited 8 July 2016.","journal-title":"J Gastrointestin Liver Dis. [Internet]"},{"key":"845_CR129","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S1473-3099(15)00074-2","volume":"15","author":"C Koh","year":"2015","unstructured":"Koh C, Canini L, Dahari H, Zhao X, Uprichard SL, Haynes-Williams V, et al. Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial. Lancet Infect Dis. [Internet]. 2015;15:1167\u201374. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473309915000742 . Cited 26 July 2017.","journal-title":"Lancet Infect Dis. [Internet]"},{"key":"845_CR130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jhep.2016.06.014","volume":"65","author":"M Rizzetto","year":"2016","unstructured":"Rizzetto M, Niro GA. Myrcludex B, a novel therapy for chronic hepatitis D? J Hepatol. [Internet]. 2016;65:465\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27538763 . Cited 26 July 2017.","journal-title":"J Hepatol. [Internet]"},{"key":"845_CR131","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jhep.2016.04.016","volume":"65","author":"P Bogomolov","year":"2016","unstructured":"Bogomolov P, Alexandrov A, Voronkova N, Macievich M, Kokina K, Petrachenkova M, et al. Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: first results of a phase Ib\/IIa study. J Hepatol. [Internet]. 2016;65:490\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27132170 . Cited 26 July 2017.","journal-title":"J Hepatol. [Internet]"},{"key":"845_CR132","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/QCO.0000000000000321","volume":"29","author":"N Abeywickrama-Samarakoon","year":"2016","unstructured":"Abeywickrama-Samarakoon N, Cortay J-C, D\u00e9ny P. The hepatitis D satellite virus of hepatitis B virus: half-opening a new era to control viral infection? Curr Opin Infect Dis. [Internet]. 2016;29:645\u201353. Available from: http:\/\/content.wkhealth.com\/linkback\/openurl?sid=WKPTLP:landingpage&an=00001432-201612000-00014 . Cited 26 July 2017.","journal-title":"Curr Opin Infect Dis. [Internet]"},{"key":"845_CR133","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1473-3099(15)00155-3","volume":"15","author":"M Rizzetto","year":"2015","unstructured":"Rizzetto M, Ciancio A. The prenylation inhibitor, lonafarnib: a new therapeutic strategy against hepatitis delta. Lancet Infect Dis. [Internet]. 2015;15:1119\u201320. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473309915001553 . Cited 26 July 2017.","journal-title":"Lancet Infect Dis. [Internet]"},{"key":"845_CR134","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1038\/s41598-017-03946-9","volume":"7","author":"K Giersch","year":"2017","unstructured":"Giersch K, Homs M, Volz T, Helbig M, Allweiss L, Lohse AW, et al. Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV\/HDV infected humanized mice. Sci Rep. [Internet]. 2017;7:3757. Available from: http:\/\/www.nature.com\/articles\/s41598-017-03946-9 . Cited 26 July 2017.","journal-title":"Sci Rep. [Internet]"},{"key":"845_CR135","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijid.2016.03.017","volume":"46","author":"LMP Borzacov","year":"2016","unstructured":"Borzacov LMP, de Figueiredo Nicolete LD, Souza LFB, dos Santos AO, Vieira DS, Salcedo JMV. Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir. Int J Infect Dis. [Internet]. 2016;46:82\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27005283 . Cited 7 Aug 2017.","journal-title":"Int J Infect Dis. [Internet]"},{"key":"845_CR136","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrgastro.2013.164","volume":"11","author":"A Ciancio","year":"2014","unstructured":"Ciancio A, Rizzetto M. Chronic hepatitis D at a standstill: where do we go from here? Nat Rev Gastroenterol Hepatol. [Internet]. 2014;11:68\u201371. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24019153 . Cited 8 July 2016.","journal-title":"Nat Rev Gastroenterol Hepatol. [Internet]"},{"key":"845_CR137","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.07.005","volume":"59","author":"EK Manesis","year":"2013","unstructured":"Manesis EK, Vourli G, Dalekos G, Vasiliadis T, Manolaki N, Hounta A, et al. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study. J Hepatol. 2013;59:949\u201356.","journal-title":"J Hepatol"},{"key":"845_CR138","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/1319-3767.91731","volume":"18","author":"Z Abbas","year":"2012","unstructured":"Abbas Z, Qureshi M, Hamid S, Jafri W. Hepatocellular carcinoma in hepatitis D: does it differ from hepatitis B monoinfection? Saudi J Gastroenterol. [Internet]. 2012;18:18\u201322. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22249087 . Cited 8 July 2016.","journal-title":"Saudi J Gastroenterol. [Internet]"},{"key":"845_CR139","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11908-012-0307-z","volume":"15","author":"B Heidrich","year":"2013","unstructured":"Heidrich B, Manns MP, Wedemeyer H. Treatment options for hepatitis delta virus infection. Curr Infect Dis Rep. [Internet]. 2013;15:31\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23242761 . Cited 8 July 2016.","journal-title":"Curr Infect Dis Rep. [Internet]"},{"key":"845_CR140","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/jnci\/djs168","volume":"104","author":"J Ji","year":"2012","unstructured":"Ji J, Sundquist K, Sundquist J. A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma. J Natl Cancer Inst. [Internet]. 2012;104:790\u20132. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22423008 . Cited 8 July 2016.","journal-title":"J Natl Cancer Inst. [Internet]"},{"key":"845_CR141","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/hep.25663","volume":"56","author":"N Freitas","year":"2012","unstructured":"Freitas N, Salisse J, Cunha C, Toshkov I, Menne S, Gudima SO. Hepatitis delta virus infects the cells of hepadnavirus-induced hepatocellular carcinoma in woodchucks. Hepatology. [Internet]. 2012;56:76\u201385. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22334419 . Cited 8 July 2016.","journal-title":"Hepatology. [Internet]"},{"key":"845_CR142","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/jmv.21078","volume":"80","author":"TJS Cross","year":"2008","unstructured":"Cross TJS, Rizzi P, Horner M, Jolly A, Hussain MJ, Smith HM, et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol. [Internet]. 2008;80:277\u201382. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18098143 . Cited 8 July 2016.","journal-title":"J Med Virol. [Internet]"},{"key":"845_CR143","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1478-3231.2009.02140.x","volume":"30","author":"K Zachou","year":"2010","unstructured":"Zachou K, Yurdaydin C, Drebber U, Dalekos GN, Erhardt A, Cakaloglu Y, et al. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver Int. [Internet]. 2010;30:430\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19840253 . Cited 8 July 2016.","journal-title":"Liver Int. [Internet]"},{"key":"845_CR144","doi-asserted-by":"crossref","first-page":"e101002","DOI":"10.1371\/journal.pone.0101002","volume":"9","author":"A Wranke","year":"2014","unstructured":"Wranke A, Heidrich B, Ernst S, Calle Serrano B, Caruntu FA, Curescu MG, et al. Anti-HDV IgM as a marker of disease activity in hepatitis delta. PLoS One. [Internet]. 2014;9:e101002. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25072849 . Cited 8 July 2016.","journal-title":"PLoS One. [Internet]"},{"key":"845_CR145","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1053\/j.gastro.2004.03.017","volume":"126","author":"P Farci","year":"2004","unstructured":"Farci P, Roskams T, Chessa L, Peddis G, Mazzoleni AP, Scioscia R, et al. Long-term benefit of interferon \u03b1 therapy of chronic hepatitis D: regression of advanced hepatic fibrosis. Gastroenterology. 2004;126:1740\u20139.","journal-title":"Gastroenterology"},{"key":"845_CR146","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/hep.1840190602","volume":"19","author":"A Madej\u00f3n","year":"1994","unstructured":"Madej\u00f3n A, Cotonat T, Bartolom\u00e9 J, Castillo I, Carre\u00f1o V. Treatment of chronic hepatitis D virus infection with low and high doses of interferon-alpha 2a: utility of polymerase chain reaction in monitoring antiviral response. Hepatology. [Internet]. 1994;19:1331\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8188163 . Cited 8 July 2016.","journal-title":"Hepatology. [Internet]"},{"key":"845_CR147","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0676.1994.tb00065.x","volume":"14","author":"A Garripoli","year":"1994","unstructured":"Garripoli A, Di Marco V, Cozzolongo R, Costa C, Smedile A, Fabiano A, et al. Ribavirin treatment for chronic hepatitis D: a pilot study. Liver. [Internet]. 1994;14:154\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8078394 . Cited 8 July 2016.","journal-title":"Liver. [Internet]"},{"key":"845_CR148","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0168-8278(02)00162-9","volume":"37","author":"C Yurdaydin","year":"2002","unstructured":"Yurdaydin C, Bozkaya H, G\u00fcrel S, Tillmann HL, Aslan N, Ok\u00e7u-Heper A, et al. Famciclovir treatment of chronic delta hepatitis. J Hepatol. 2002;37:266\u201371.","journal-title":"J Hepatol"},{"key":"845_CR149","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/hep.21325","volume":"44","author":"C Castelnau","year":"2006","unstructured":"Castelnau C, Le Gal F, Ripault M-P, Gordien E, Martinot-Peignoux M, Boyer N, et al. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology. [Internet]. 2006;44:728\u201335. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16941695 . Cited 8 July 2016.","journal-title":"Hepatology. [Internet]"},{"key":"845_CR150","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.21296","volume":"44","author":"GA Niro","year":"2006","unstructured":"Niro GA, Ciancio A, Gaeta GB, Smedile A, Marrone A, Olivero A, et al. Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. Hepatology. [Internet]. 2006;44:713\u201320. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16941685 . Cited 8 July 2016.","journal-title":"Hepatology. [Internet]"},{"key":"845_CR151","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1440-1746.2006.04082.x","volume":"21","author":"B Canbakan","year":"2006","unstructured":"Canbakan B, Senturk H, Tabak F, Akdogan M, Tahan V, Mert A, et al. Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: a randomized trial. J Gastroenterol Hepatol. [Internet]. 2006;21:657\u201363. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16677149 . Cited 8 July 2016.","journal-title":"J Gastroenterol Hepatol. [Internet]"},{"key":"845_CR152","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2893.2007.00936.x","volume":"15","author":"C Yurdaydin","year":"2008","unstructured":"Yurdaydin C, Bozkaya H, Onder FO, Sent\u00fcrk H, Karaaslan H, Akdo\u011fan M, et al. Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon. J Viral Hepat. [Internet]. 2008;15:314\u201321. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18307594 . Cited 8 July 2016.","journal-title":"J Viral Hepat. [Internet]"},{"key":"845_CR153","first-page":"1648","volume":"58","author":"N Ormeci","year":"2011","unstructured":"Ormeci N, B\u00f6l\u00fckba\u015f F, Erden E, Coban S, Ekiz F, Erdem H, et al. Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months. Hepatogastroenterology. [Internet]. 2011;58:1648\u201353. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22086695 . Cited 8 July 2016.","journal-title":"Hepatogastroenterology. [Internet]"},{"key":"845_CR154","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa0912696","volume":"364","author":"H Wedemeyer","year":"2011","unstructured":"Wedemeyer H, Yurdayd\u00ecn C, Dalekos GN, Erhardt A, \u00c7akalo\u011flu Y, De\u011fertekin H, et al. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med. [Internet]. 2011;364:322\u201331. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21268724 . Cited 8 July 2016.","journal-title":"N Engl J Med. [Internet]"},{"key":"845_CR155","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3851\/IMP2381","volume":"18","author":"C Karaca","year":"2013","unstructured":"Karaca C, Soyer OM, Baran B, Ormeci AC, Gokturk S, Aydin E, et al. Efficacy of pegylated interferon-\u03b1 treatment for 24 months in chronic delta hepatitis and predictors of response. Antivir Ther. [Internet]. 2013;18:561\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22976528 . Cited 8 July 2016.","journal-title":"Antivir Ther. [Internet]"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-017-0845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T16:15:55Z","timestamp":1692980155000},"score":1,"resource":{"primary":{"URL":"http:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-017-0845-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,13]]},"references-count":155,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["845"],"URL":"https:\/\/doi.org\/10.1186\/s12985-017-0845-y","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,13]]},"article-number":"177"}}